Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapiscan vs Adenosine for FFR Measurement
NCT01809743Phase 3Completed
- Start
- Jan 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of regadenoson in coronary artery disease (CAD). Started Jan 2013; status: completed.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01809743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01809743.